Join The Analytical Scientist and Thermo Fisher Scientific on March 17, 2020 for an educational webinar on automating sample preparation for LC-MS proteomic workflows. Find out more

This application note demonstrated a quantitative analysis of poly(methyl methacrylate) contamination on the 0.1% level with a calibration curve. Read More.

This application note shows the advantages of immersive sorptive extraction using high-capacity HiSorb™ probes for GC–MS analysis of a wide range of aroma compounds in vodka. Read More.

Eleven elements in a HF digested soil SRM were determined using a 5110 ICP-OES with an inert sample introduction system. Recoveries were all within ± 10%, with excellent precision over 7 hours. Read More

ACQUITY APC system used in conjunction with OMNISEC REVEAL multi-detector provides more information, more quickly and with less sample. Read More.

Adaptive Correlation provides an improvement in the repeatability of DLS particle size measurements and the ability to measure primary particle sizes separately to the characterization of rare amounts of aggregated material. Read More.

The alpha300 Ri combines the advantages of an inverted beam path with all the functionality of WITec’s 3D confocal Raman imaging microscopes for measurements on biological, liquid or bulky samples. Read More.

HÜBNER Photonics introduces the Cobolt 08-NLDM 785 nm, with enhanced spectral purity. HÜBNER Photonics now offers the widest selection of Cobolt lasers for Raman spectroscopy. Read More.

The Analytical Scientist is committed to providing you with content that is relevant and of the highest quality. Tell us what you think of The Analytical Scientist in our short survey and you could win a $100 Amazon voucher!

SLAS introduces the Networking Membership -- $25/year for access to the SLAS CONNECTED online community for collaboration & networking. Ask Qs. Talk tech. Find collaborators. Join a Special Interest. Read More.

Explore an array of targets and therapies, manufacturing processes, regulatory frameworks, clinical studies and market opportunities for cannabinoid-based pharmaceuticals at the iCBD³ Congress. Read More.